Intezyne Technologies

Intezyne Technologies develops synthetic polymers for drug delivery and the treatment of cancer.

Intezyne Technologies, Inc., a biomedical research company, engages in developing synthetic polymers for drug delivery and the treatment of cancer. The company develops IVECT Method to limit chemotherapeutics' anti-tumor activity to within the tumor itself. Its IVECT Method could deliver various classes of small molecules, nucleic acids, oligopeptides, and diagnostic imaging agents. Intezyne Technologies was founded in 2004...